Filter by:
Competitive Intelligence

Informing digital health strategy in dermatology

A major pharmaceutical company asked us to assess emerging dermatology digital health solutions targeted to either patients or health care practitioners.

View Case Study

Portfolio, Licensing and Development

Identifying high value global in-licensing targets in the RNA/ASO space

A top pharmaceutical company sought to evaluate emerging approaches in intracellular delivery and tissue-specific targeting of RNA/ASO molecules.

View Case Study

Marketing and Commercial Strategy

Characterizing the patient journey for an inpatient initiated antibiotic

A biotechnology company launching an IV antibiotic wanted to track commercial uptake and differences in patient characteristics for those who received their drug vs. other treatments.

View Case Study

Market Access and Reimbursement

Evaluating innovative contracting and reimbursement for emerging gene therapy

Acquiring company sought to probe the reimbursement landscape and innovative contracting considerations for a gene therapy in development.

View Case Study

Competitive Intelligence

Performing multi-year ongoing competitive intelligence threat assessments and monitoring

A mid-sized EU pharmaceutical company sought to track global threats to their psychiatric portfolio. They needed accurate and recurring risk assessments of emerging competitors based on clinical success and product overlap.

View Case Study

Market Access and Reimbursement

Assessing hospital reimbursement dynamics for a post-operative pain medication

Client sought to understand reimbursement dynamics that might influence uptake for a postoperative pain medication (e.g. quality metrics, guidelines).

View Case Study

Marketing and Commercial Strategy

Developing positioning, targeting and training for a new value framework assessment tool

A vendor to the life sciences industry was launching a new product focused on value assessment for emerging pharmaceuticals and sought guidance around positioning and appropriate target audience.

View Case Study

Marketing and Commercial Strategy

Informing forecasting and epidemiology analyses for oncology tumors

A world-leading biotechnology company sought to understand epidemiology and subpopulation assumptions across a number of countries for various oncology tumor types.

View Case Study

Portfolio, Licensing and Development

Assessing strategy across 4 immunology areas to inform franchise and acquisition approach

A top 10 pharmaceutical company sought to examine unmet needs, reimbursement landscape (US, EU, Japan) and emerging competitors across 4 immunology therapeutic areas.

View Case Study

© 2021 Opus Strategy, LLC